Hunan Hansen Pharmaceutical has obtained approval for the extension of the protection period of Simitang Oral Liquid, a nationally protected traditional Chinese medicine.
Hansen Pharmaceutical (002412.SZ) announced that the National Medical Products Administration website has issued a notice "Regarding the Announcement of Protected Traditional Chinese Medicine Varieties (Extension...".
Hunan Hansen Pharmaceutical (002412.SZ) announced that the National Medical Products Administration has extended the second-level protection for the company's Simotang Oral Liquid. According to the announcement, the functions of Simotang Oral Liquid are to regulate qi, relieve nausea, reduce stagnation, and alleviate pain. It is used for infant and child indigestion with symptoms such as abdominal distension, abdominal pain, crying, poor appetite, diarrhea or constipation; elderly indigestion with symptoms such as abdominal distension, abdominal pain, and constipation; and to promote the recovery of gastrointestinal function after abdominal surgery.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


